David Armistead

David Armistead

Nessuna posizione attualmente
Finance
Consumer Services
Health Technology

Profilo

Dr. David Armistead is Entrepreneur-in-Residence at Third Rock Ventures LLC.
Prior to joining Thrid Rock ventures in 2010.
He was with Oxford Bioscience Partners.
He was Vice President and Site Head for the Amgen Cambridge Research Center, where he oversaw all aspects of the East Coast research activities for Amgen Inc. In 1997, he was a co-founder of Kinetix Pharmaceuticals, where he held the position of Vice President of Research and Development and Chief Scientific Officer until the acquisition of Kinetix by Amgen in December 2000.
Previously, he held the position of Head of Immunosuppressive Research and Development and Senior Scientist-Medicinal Chemistry at Vertex Pharmaceuticals.
Prior to that, he held the position of Senior Research Chemist in Inflammation and Immunology at Merck Sharp and Dohme Research Laboratories (Merck & Co., Inc.).
He left Merck to become a founding member of Vertex in 1989.
Dr. Armistead holds a Bachelor of Arts and a Master of Science in Chemistry from Virginia Polytechnic Institute, a Ph.D.
in Synthetic Chemistry from the University of South Carolina and was a National Institutes of Health Postdoctoral Fellow at Yale University.

Precedenti posizioni note di David Armistead

SocietàPosizioneFine
Investitore di Private Equity 31/07/2010
Corporate Officer/Principal -
Direttore Tecnico/Scientifico/R&S -
BLUEPRINT MEDICINES CORPORATION Fondatore -
Vedi nel dettaglio l'esperienza di David Armistead

Formazione di David Armistead

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

16

Relazioni di 1° grado

6

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private6

Finance

Consumer Services

Consumer Services

Health Technology

Finance

Health Technology

  1. Mercati
  2. Insider
  3. David Armistead